This company has shut down. Systemic Bio is no longer operating — its last tracked round was a Seed in 2022.
Explore the Startup GraveyardSystemic Bio creates bioprinted organs-on-chips for drug discovery and development.
Systemic Bio has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in September 2022.
Systemic Bio's investors include 3D Systems.
Systemic Bio is headquartered in Houston, United States.
Systemic Bio creates bioprinted organs-on-chips for drug discovery and development.
Systemic Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Systemic Bio — Funding & Investors." VCBacked, September 8, 2022, https://www.vcbacked.co/company/systemic-bio. Accessed August 13, 2026.
VCBacked. (2022). Systemic Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/systemic-bio
{{cite web |title=Systemic Bio — Funding & Investors |url=https://www.vcbacked.co/company/systemic-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated